RBC Capital Cuts PT on Nuvation Bio (NUVB) in Q2 Preview
Nuvation Bio Inc. (NYSE:NUVB) is one of the best small cap stocks to buy with the highest upside potential. RBC Capital lowered the price target on Nuvation Bio Inc.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Decheng Capital Min Cui | 25,954,439 | $147,421,214 | 20.15% | |
| 2. | Laurion Capital Management Benjamin A. Smith | 7,820,013 | $44,417,674 | -1% | 1.14% |
| 3. | 27,500,000 | $28,759,898 | 0.01% | ||
| 4. | Tang Capital Management Kevin C. Tang | 3,299,557 | $18,741,484 | +5% | 0.85% |
| 5. | Redmile Group Jeremy Green | 3,031,009 | $17,216,131 | -4% | 1.16% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.73 | 25,000 | $118,250.00 | 225,000 | 2026-06-09 | Filing | |
| $1.71 | 10,000 | $17,100.00 | 29,591 | 2025-06-18 | Filing | |
| $1.79 | 4,000 | $7,160.00 | 9,902 | 2025-06-17 | Filing | |
| $1.84 | 3,300 | $6,055.50 | 5,902 | 2025-06-16 | Filing | |
| $1.81 | 50,000 | $90,350.00 | 81,000 | 2025-06-16 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.09 | 100,000 | $709,240.00 | 0 | 2026-08-19 | Filing | |
| $6.03 | 125,000 | $753,187.50 | 32,591 | 2026-06-23 | Filing | |
| $6.02 | 63,000 | $379,190.70 | 53,000 | 2026-06-23 | Filing | |
| $6.01 | 47,668 | $286,370.28 | 12,673 | 2026-06-23 | Filing | |
| $5.01 | 36,750 | $184,279.20 | 53,000 | 2026-04-17 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 52,230,295 | $296,668,075 | 0.01% | |
| 2. | 27,630,837 | $156,943,154 | 0% | |
| 3. | 11,919,514 | $67,702,840 | 0% | |
| 4. | 52,584,000 | $54,932,390 | 0.28% | |
| 5. | 8,081,089 | $45,900,586 | 24.72% |